1 / 22

Were the objectives generally met?

Were the objectives generally met? . Yes Somewhat No. 10. Did you feel able to contribute?. Yes Somewhat No. 10. Was your opinion listened to?. Yes Somewhat No N/A. 10.

seda
Download Presentation

Were the objectives generally met?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Were the objectives generally met? Yes Somewhat No 10

  2. Did you feel able to contribute? Yes Somewhat No 10

  3. Was your opinion listened to? Yes Somewhat No N/A 10

  4. Did any of your opinions about the benefits of early HIV treatment become more positive as a result of this meeting? Yes Somewhat No 10

  5. How confident were you before the start of the workshop about recommending early treatment for your HIV positive patients? Very confident, I know everything there is to know about starting HIV treatment Somewhat confident Neither Somewhat unsure Very unsure, I really wasn’t confident about starting treatment early 10

  6. How confident were you at the end of the workshop about recommending early treatment for your HIV positive patients? Very confident, I know everything there is to know about starting HIV treatment Somewhat confident Neither Somewhat unsure Very unsure, I really wasn’t confident about starting treatment early 10

  7. What patient related issues will most influence clinicians to start treatment early? (select one option which you feel most strongly applies) Patient preparedness, adherence, good indications, knowledge of patient Patient request, choice, desire, preference Patient has symptoms Serodiscordantrelationship, transmission risk, public health Recreational drug use, lifestyle 10

  8. Which, if any, of the following issues will most influence clinicians to start treatment early? (select one option which you feel most strongly applies) Risk benefit analysis, clinical benefit versus risk, avoidance of harm Scientific data, PARTNER study, etc Clinical consensus, confidence, guidelines Ability to prescribe at any CD4, PBAC change 10

  9. Which of the following patient-related factors will most influence clinicians to recommend PrEP? (select one option which you feel most strongly applies) Ongoing risk of exposure, serodischordant relationships Clinician’s knowledge of the patient Patient willingness, eagerness Patient’s perceived capacity to maintain adherence 10

  10. Which of the following issues will most influence clinicians’ to recommend PrEP? (select one option which you feel most strongly applies) Availability, access, trials Cost, funding, who will pay Data from studies Guidelines for use, defined populations in which to use 10

  11. Were the objectives generally met?

  12. Did you feel able to contribute?

  13. Was your opinion listened to?

  14. Did any of your opinions about the benefits of early HIV treatment become more positive as a result of this meeting?

  15. How confident were you before the start of the workshop about recommending early treatment for your HIV positive patients?

  16. How confident were you at the end of the workshop about recommending early treatment for your HIV positive patients?

  17. What patient related issues will most influence clinicians to start treatment early?

  18. Which, if any, of the following issues will most influence clinicians’ to start treatment early?

  19. Which of the following patient-related factors will most influence clinicians’ to recommend PrEP?

  20. Which of the following issues will most influence clinicians’ to recommend PrEP?

More Related